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Abstract The Ritvo Autism Asperger Diagnostic Scale-
Revised (RAADS-R) is a valid and reliable instrument to
assist the diagnosis of adults with Autism Spectrum Dis-
orders (ASD). The 80-question scale was administered to
779 subjects (201 ASD and 578 comparisons). All ASD
subjects met inclusion criteria: DSM-IV-TR, ADI/ADOS
diagnoses and standardized IQ testing. Mean scores for each
of the questions and total mean ASD vs. the comparison
groups’ scores were significantly different (p \ .0001).
Concurrent validity with Constantino Social Responsive-
ness Scale-Adult = 95.59%. Sensitivity = 97%, specific-
ity = 100%, test–retest reliability r = .987. Cronbach
alpha coefficients for the subscales and 4 derived factors
were good. We conclude that the RAADS-R is a useful
adjunct diagnostic tool for adults with ASD.
Keywords Diagnosis  Autism  Asperger’s disorder 
RAADS-R
Introduction
The RAADS was designed to address a major gap in
screening services for adults with autism spectrum disor-
ders. With the increased prevalence of the condition and
the fact that adults are being referred or self-referred for
services or diagnosis with increasing frequency, this
instrument is a useful clinical tool to assist clinicians with
the diagnosis of this growing population of higher func-
tioning individuals in adulthood. This study was designed
to standardize the Ritvo Autism Asperger Diagnostic
Scale-Revised (RAADS-R) in a large number of subjects at
nine centers on three continents.
The RAADS-R is a modified version of the Ritvo Aut-
ism Asperger’s Diagnostic Scale (Ritvo et al. 2008). The
rationale for its development was the need for a clinical
adjunct diagnostic tool. While several diagnostic scales for
children and adolescents with ASD are available (Attwood
1998; Ehlers et al. 1999), only one peer- reviewed scale,
The Autism-Spectrum Quotient (AQ) was designed spe-
cifically for adults (Baron-Cohen et al. 2001). Its authors
emphasize that it is useful in identifying autistic traits and
as a screening instrument but not as a diagnostic tool. The
AQ is mailed in by the participant, unlike the RAADS-R,
which is designed to be administered by a clinician in
a clinical setting. Baron-Cohen et al. (2005) propose
a diagnostic system as well: The Adult Asperger’s
R. A. Ritvo
The Child Study Center, Yale University School of Medicine,
New Haven, CT, USA
E. R. Ritvo  D. Guthrie
The Geffen School of Medicine at UCLA, Los Angeles, CA,
USA
M. J. Ritvo  D. H. Hufnagel
Yale College, New Haven, CT, USA
W. McMahon
University of Utah School of Medicine, Salt Lake, UT, USA
B. Tonge
Monash University, Melbourne, VIC, Australia
D. Mataix-Cols  A. Jassi
King’s College London, London, UK
T. Attwood  J. Eloff
Griffith University, Brisbane, QLD, Australia
R. A. Ritvo (&)
11941 Saltair Terrace, Los Angeles, CA 90049, USA
e-mail: ariella.ritvo@yale.edu
123
J Autism Dev Disord (2011) 41:1076–1089
DOI 10.1007/s10803-010-1133-5
Assessment (AAA): A Diagnostic Method. While the
AAA is a good system, it is a complete diagnostic
system, unlike the RAADS-R. It is lengthy and compli-
cated to administer and is still relatively new. The initial
RAADS was developed around the same time period.
The original RAADS contains 78 empirically derived
questions that assess symptoms based upon DSM-IV-TR
(American Psychiatric Association 2000) and ICD-10
World Health Organization (1992) diagnostic criteria that
were extensively tested prior to inclusion on the scale. It
proved accurate in discriminating autistic and Asperger’s
subjects (N = 37) from comparison subjects (N = 57)
when tested (e.g., sensitivity = 1, specificity = 1). Sev-
enty-six of the 78 questions significantly distinguished
ASD subjects from comparison subjects (Ritvo et al.
2008).
Questions on the initial RAADS assess developmental
pathology in three symptom areas: language, social relat-
edness, and sensory-motor (re: DSM-IV-TR). After critical
review and the results of a factor analysis, a revised 80-
item version was developed (the RAADS-R) with the
addition of a fourth symptom area (circumscribed inter-
ests), two questions, and several word clarifications. Like
the RAADS, the RAADS-R is a self-report instrument,
designed for adults (18 ?) with average or above average
intelligence.
In order to validate the RAADS-R, a uniform research
protocol was developed to be implemented at nine research
centers on three continents. The protocol assured unifor-
mity of diagnosis and data acquisition, and its implemen-
tation in multiple centers afforded an opportunity to assess
the applicability of the scale in a variety of international
clinical settings: (a) UCLA; (b) The Child Study Center,
Yale University; (c) University of Utah; (d) Mt. Sinai
Medical School, New York; (e) The Geneva Center, Tor-
onto, Canada; (f) King’s College, London, England; (g)
Monash University, Melbourne, Australia; (h) Griffith
University, Brisbane, Australia; and (i) ASPECT, Sidney,
Australia.
At the time this research was concluding, the American
Psychiatric Association’s DSM-V committee proposed
new diagnostic criteria for Autism Spectrum Disorders
(APA DSM-5 2010). These new guidelines propose com-
bining individuals who meet the DSM-IV-TR criteria for
Autistic Disorder and Asperger’s Disorder into one cate-
gory called Autistic Spectrum Disorder (ASD). The results
of this study will present subjects grouped according to
both the DSM-IV-TR and proposed DSM-V criteria. There
has been ongoing controversy among clinicians about the
relationship of autism and Asperger’s disorder. Diagnostic
approaches and definitions are described in the literature
(Fitzgerald and Corvin 2001; Klin et al. 2005; Volkmar and
Lord 1998).
Methods
Participants
Research Centers and Informed Consents
Nine centers on three continents were selected to provide a
worldwide spectrum of English speaking subjects. Human
Subject Protection Protocol and Consent to Participate
Forms were approved by the California Institutional
Review Board, Pasadena, California for all UCLA subjects,
and served as models for the other centers to assure uni-
formity. Each center has ongoing clinical and research
programs focusing on autism, and each center complied
with their rules and regulations concerning the protection
of human subjects. Each of the nine centers provided
autistic and Asperger’s disorder subjects and some also
contributed comparison subjects.
Participant Grouping
The study population included 4 groups as follows: (a)
subjects with a diagnosis of Autistic Disorder (n = 66), (b)
subjects with a diagnosis of Asperger’s Disorder
(n = 135), (c) subjects with no previous DSM-IV-TR
diagnosis (n = 276), and (d) subjects with an axis I DSM-
IV-TR diagnosis other than Autistic Disorder, Asperger’s
Disorder, or PDD NOS (n = 302). Subjects in this group
had the following diagnoses: Social Phobia, Schizophrenia,
Major Depressive Disorder, Bipolar Disorder Type I and II,
Obsessive Compulsive Disorder, Dysthymic Disorder,
Generalized Anxiety Disorder, Post Traumatic Stress Dis-
order, Psychotic Disorder NOS, Anorexia Nervosa and
Polysubstance Dependence. For some data analyses, the
above groups were collapsed into two groups as follows:
(a) Autism Spectrum Disorder (ASD) subjects (N = 201),
and (b) all comparison subjects (N = 578). No participants
from either group declined to participate.
Inclusion Criteria
A standardized research protocol was implemented at each
of the nine centers to assure uniformity of diagnosis. All
ASD subjects had to meet the following criteria: (a) a
clinical DSM-IV-TR diagnosis of autistic or Asperger’s
disorder, (b) an ADI/ADOS or at least an ADOS module 4
scale to assure they met the cut off for ASD, and (c) a Full
Scale IQ score of 80 or above. If prior formal IQ test results
were not available, a WAIS or a WASI was administered.
Constantino’s Social Responsiveness Scale-Adult Research
Version (SRS-A) was obtained if a suitable informant
accompanied the subject, as it is a second party rating scale
(a second party rating scale is administered to a person
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other than the subject who answers questions about the
subject, such as a family member or a friend). The SRS was
selected because it is easy to administer and is reported to
have good psychometric properties: internal consistency
0.91–0.97, test–retest reliability 0.84–0.97 and interrater
reliability 0.74–0.95 (Bolte et al. 2008). The respondents
completing the measure in this study were spouses, parents
and siblings. A subset of subjects at UCLA was retested
after an average of 1 year to determine test–retest
reliability.
Two groups of comparison subjects were selected. The
first consisted of 276 volunteers who did not have, and
never had a DSM-IV-TR diagnosis. They were recruited
from clinic staff members and students, and were indi-
vidually administered the scale by a research staff mem-
ber. The second group consisted of 302 volunteers
recruited at an adult psychiatric out-patient clinic. They
were formally diagnosed as having a DSM-IV-TR diag-
nosis other than ASD by an experienced board certified
psychiatrist or a licensed psychologist who administered
the scale individually to each. The majority of the com-
parison cases were recruited by the principal investigator
and UCLA.
Materials
Design of the Revised Scale: The RAADS-R contains 64
symptom-based questions and 16 non-symptom based
responses (see Appendix 1 for scale and Appendix 2 for
scoring instructions). The questions were divided into four
sub scales per DSM-IV-TR criteria as follows:
1. Social Relatednesss—total of 39 questions: 1, 6, 8, 11,
14, 17, 18, 25, 37, 38, 3, 5, 12, 28, 39, 44, 45, 76, 79,
80, 20, 21, 22, 23, 26, 31, 43, 47, 48, 53, 54, 55, 60, 61,
64, 68, 69, 72, 77.
2. Circumscribed Interests—total of 14 questions: 9, 13,
24, 30, 32, 40, 41, 50, 52, 56, 63, 70, 75, 78.
3. Language—total of 7 questions: 2, 7, 27, 35, 58, 66, 15.
4. Sensory Motor—total of 20 questions: 10, 19, 4, 33, 34,
36, 46, 71, 16, 29, 42, 49, 51, 57, 59, 62, 65, 67, 73, 74.
Procedures
Administration of the RAADS-R to ASD Subjects
Following initial screening, a clinician interviewed each
subject to confirm the diagnostic information and IQ data,
completed the ADI/ADOS or ADOS module 4, and then
introduced the scale and explained how to answer the
questions. The clinician remained with each subject as the
questions were being answered to offer clarifications when
asked, and to make sure answers were entered in the proper
columns on the Likert scale. An SRS-A scale was obtained
from cooperating accompanying adults when available.
Administration of the RAADS-R to Comparison Subjects
After initial diagnostic and IQ screening, all were given the
RAADS-R to complete in the presence of a clinician. Each
of the nine participating centers was asked to score, review,
and mail in full packets of ASD subjects. Some of the
participating centers contributed data to the comparison
group subject pool.
Data Analysis
Data were coded by each center to preserve anonymity prior
to being sent to UCLA. Data were then recoded and entered
into an Excel spreadsheet and then transferred to SAS and
MPlus for statistical analyses. Exploratory factor analysis
was carried out using both orthogonal and oblique varimax
rotation under maximum likelihood estimation. A scree plot
of the eigenvalues was examined to determine the number
of factors. A confirmatory factor analysis was carried out on
the final factors using robust weighted least squares
(WLSMV) estimation methods as the original items are
ordinal. The factor loadings were compared across gender
and ASD subgroups to assess constancy (differential item
function analysis). Cronbach alpha was also computed to
assess the internal consistency of the derived factors.
Unadjusted means were compared using one-way analysis
of variance and demographics adjusted means were com-
pared using analysis of covariance methods. Associations
between continuous variables were assessed using Pearson
correlations. Sensitivity, specificity and accuracy of a given
factor or score for distinguishing between ASD versus non
ASD was computed using non-parametric ROC (receiver
operator characteristic) methods. Unweighted accuracy is
defined as the average of sensitivity and specificity. The
optimal threshold (cut point) was defined as the value of the
given factor or score that maximized accuracy.
Results
Subjects’ Demographics
Table 1 contains the sex distribution and demographic
characteristics of the four subject groups.
Diagnostic Accuracy (Sensitivity and Specificity)
The total RAADS scores ranged from 44 to 227 in the ASD
subjects and from 0 to 65 in the comparison groups. By
ROC curve analysis, we determined that the best threshold
1078 J Autism Dev Disord (2011) 41:1076–1089
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for distinguishing between the two groups was a score
of 65. Using this value, all 578 comparison subjects
were correctly predicted with no ‘‘false positives’’
(specificity = 100%).
Six ASD subjects from three of the nine centers scored
below the threshold (non-ASD predicted range). These
‘‘false negatives’’ yielded a sensitivity of 97% (see Table 2).
Table 3 shows the sensitivity, specificity and accuracy
for the original four subscale domains and the four factors
as well as the total RAADS-R score. As can be seen, the
total RAADS-R score has the highest accuracy.
Group Comparisons
One-way ANOVA comparisons across all groups, mean
RAADS-R scores, and statistical characteristics of subject
groups are contained in Table 4. The means and statistical
characteristics obtained after collapsing the four groups
into two (all ASD subjects vs. all comparison subjects) are
shown in Table 5. The mean RAADS-R scores of the ASD,
the autistic, and the Asperger’s disorder groups (Tables 3
and 4) were significantly different from the means of the
comparison groups (p \ .0001). This was also true at each
of the nine research centers. The original subscale domains,
the factors and the total score are all significantly different
in ASD versus non ASD.
An age and sex adjusted ANOVA of total RAADS-R
scores and subscale scores, across diagnostic groups
showed group differences. Sex was not significant as a
main effect (p = .06) but sex-diagnosis was significant
(p = .0043). The effect of diagnosis slightly varied by sex,
however, diagnosis was the strongest effect. Age was sig-
nificant as a main effect (p = .0035) and age-diagnosis
effect was also significant (p \ .05). In ASD subjects, an
increase in age was positively correlated with an increase
Table 1 Demographic characteristics of the study sample
Group N Males Females Mean age Married % Highest grade % Mean IQ
N % N % High school College Graduate
Autistic disorder 66 52 79.1 14 20.9 30.81 13.4 52.2 37.3 10.4 114
Asperger’s disorder 135 93 68.9 42 31.1 32.01 21.5 37.8 53.3 7.4 122
ASD 201 145 72.1 56 27.9 31.45 18.9 45.0 45.3 8.9 119
No DSM-IV-TR 276 114 41.3 162 58.7 41.51 39.5 37.7 46.0 16.3 116
Other DSM-IV-TR 302 134 44.4 168 55.6 42.04 28.5 40.1 53.3 6 112
Comparisons 578 248 42.9 330 57.1 41.78 33.7 38.9 49.65 11.15 114
Full sample 779 394 44.4 386 49.5 29.9 39.9 49.4 10.3 116.5
Table 2 Characteristics of the only 6 ASD subjects (3%) whose
mean RAADS-R scores were below 65 (false negatives) (mean
age = 19.9)
Center Diagnosis Age Sex School IQ RAADS-R
YALE ASPERGER 19 M HS 120 52
GRIFITH ASPERGER 23 M HS 117 56
ASPEC AUTISTIC 18 M HS 116 58
GRIFITH ASPERGER 19 M HS 122 58
YALE ASPERGER 20 M COL 116 59
YALE ASPERGER 19 M COL 116 60
Table 3 Accuracy in distinguishing ASD (N = 201) from non-ASD
(N = 578) (ROC analysis)
Variable Thresholda Sensitivity
%
Specificity
%
Accuracy
%
Original subscale Dom
Social construct 31 96.0 96.2 96.1
Circumscribed
interest
15 89.6 97.1 93.3
Sensory motor 16 85.1 95.2 90.2
Language 4 88.6 91.5 90.1
Total score 65 97 100 98.5
Factor 1—Social
related
0.13 78.7 93.8 86.2
Factor 2—
Circumscribed int.
0.34 86.6 95.5 91.1
Factor 3—Sensory
motor
0.36 71.8 92.5 82.2
Factor 4—Social
anxiety
0.17 76.7 74.2 75.5
a Value that best separates ASD from non ASD in SD units
Table 4 One way ANOVA comparisons and statistical characteristics
of participant groups
Group autistics N Mean Min Max SEp SD
Autistics 66 138.46 44 227 4.61 41.4
Asperger 135 131.53 52 225 3.24 35.73
No diagnosis 276 21.39 0 65 0.93 65
Other diagnosis 302 30.11 2 65 0.89 65
This ANOVA is for total RAADS-R score by group
F = 286, df = 3, p \ .0001
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in mean RAADS-R scores. (Spearman correlation 0.37,
p = .0003). However, age–sex–diagnosis effect was not
significant (p = .1299). Repeated analyses after adjustment
for sex and age between and among the subject groups
showed significant differences between ASD and compar-
ison groups (p \ .0001).
Pair-Wise Comparison of Each Question
Post-hoc unequal variance t tests were performed for
pair-wise comparison of each of the 80 questions. The
ASD subjects had significantly greater scores on each of
the individual RAADS-R items (N = 80) than either of
the comparison groups (p \ .0001 for all comparisons).
Total RAADS-R mean scores between autistic and
Asperger’s disorder subject groups were not significantly
different.
Validity Measures
All ASD subjects met the research diagnostic criteria of
each center and had an ADOS module 4 score in the autism
range (these were inclusion criteria). SRS-A scales were
administered to 69 first-degree relatives of ASD subjects.
The concordance rate was 95.59% (all but three scored in
the ‘‘autism’’ range).
Analysis of the Subscales
Mean scores and Cronbach alpha correlation coefficients
were computed for each of the four subscale domains
described previously: circumscribed interests = .903, lan-
guage = .789, sensory motor = .905, social related-
ness = .923 (for the four participant groups’ mean scores
of the subscales, see Table 6).
Factor Analysis
Factor Analysis was carried out using both varimax
(orthogonal) and oblique (non-orthogonal) varimax rota-
tion. The oblique rotational method was preferred because
it assumes the underlying constructs to be interrelated. In
addition, the oblique model had simpler factor structure
that was easier to interpret.
Four factors were identified using the oblique rotation
method. These factors had a simpler factor structure with
much less cross loading compared to the orthogonal results,
making for easier interpretation. These final oblique factors
also had a higher correlation with the original subscales
compared to the orthogonal factors. Factors I and IV cor-
related most strongly with the social construct (r = .80).
Factor II correlated most strongly with circumscribed
interests (r = .78), factor III with sensory motor (r = .88).
The language construct was not picked up with the four-
factor model. The variables determined below are based on
factor scores.
1. Factor I: Social Relatedness, containing questions
related to empathy, intimacy and social language
accounted for 23.9% of the variance. Questions: 1, 6,
8, 11, 13, 14, 15, 16, 18, 31, 37, 38, 43, 48, 52, 53, 58,
62, 66, 68, 72, 74, 77; a = .93.
Table 5 Means and statistical characteristics for total score, ASD vs. comparison groups
Group Mean SEp SD Range S–W Skewness Kurtosis Effect size
Autistic spectrum (n = 201) 133.83 2.66 37.74 44–227 0.993 0.09 -0.18 4.56
Comparison controls (n = 578) 25.95 0.67 16.04 0–65 0.959 0.42 -0.76
S–W Shapiro-Wilkes normality statistic
F = 1,522.44, df = 1, p \ .0001
Table 6 Statistical analysis of the subscales
Group Subscale Mean SD
Autistic spectrum (n = 66)
Social 67.89 21.45
Sensory motor 32.82 12.25
Circumscribed interests 28.11 8.54
Language 11.08 4.54
Asperger (n = 135)
Social 65.07 17.80
Sensory motor 28.96 13.07
Circumscribed interests 27.44 8.76
Language 10.06 4.37
No DSM IV (n = 276)
Social 9.24 7.70
Sensory motor 5.26 5.33
Circumscribed interests 5.03 4.44
Language 1.86 2.46
Other DSM IV (n = 302)
Social 13.88 9.95
Sensory motor 7.72 4.92
Circumscribed interests 7.08 4.69
Language 1.43 1.76
p \ .0001
1080 J Autism Dev Disord (2011) 41:1076–1089
123
2. Factor II: Circumscribed Interests, also with questions
relating to social blindness, accounted for 25.0% of the
variance. Questions: 3, 4, 5, 7, 9, 12, 16, 17, 20, 22, 25,
27, 28, 32, 33, 39, 41, 44, 45, 49, 50, 56, 60, 64, 76, 78,
79, 80; a = .95.
3. Factor III: Sensory Motor accounted for 22.4% of the
variance. Questions: 2, 10, 19, 24, 29, 34, 35, 36, 40,
46, 51, 54, 57, 59, 65, 70, 71, 73; a = .87.
4. Factor IV: Social Anxiety accounted for 18.9% of the
variance. Questions: 21, 23, 26, 30, 42, 47, 55, 61, 63,
67, 69, 75; a = .89.
A confirmatory factor analysis using these four factors
showed that the coefficient of variation of the factor
loadings was 20, 18, 18, and 19%, respectively, implying
similar loadings for each item within a given factor. A
comparison of factor loadings (differential item function)
by gender and by ASD vs. non-ASD showed no significant
differences with the mean difference of 18% or less.
Test–Retest Reliability
Fifteen ASD subjects and fifteen comparison subjects
without another DSM-IV-TR diagnosis were retested at
UCLA after a mean interval of 1 year (maximum interval
15 months, minimum interval 10 months) The initial
RAADS-R mean score for the ASA subjects was 155, and
when repeated was 149. The initial RAADS-R mean score
for the comparison subjects was 20, and 21 when repeated
(Table 7 contains the statistical analyses for test–retest
data).
University/Center Effect
The total mean RAADS-R scores for the ASD subjects
from each of the 9 centers were significantly different from
the comparison groups (p \ .0001) and there were signif-
icant differences between the universities (see Table 8).
Clinical Implications of RAADS-R Scores
A RAADS-R score of 65 or greater is consistent with a
clinical diagnosis of ASD. A RAADS-R score of 64 or
lower is not consistent with a diagnosis of ASD (sensitiv-
ity = 97%, specificity = 100%). It must be emphasized,
however, that if a subject has a score of 64 or lower but
clinical judgment indicates that ASD is present, the clinical
judgment should take precedence. This is due to the many
limitations of self-rating scales that will be elaborated upon
in the discussion section.
Discussion
The RAADS-R is a highly specific (100%) and sensitive
(97%) instrument that is useful as an adjunct clinical
diagnostic tool. Based on the results of this study and the
RAADS pilot study, a RAADS-R score of 65 or higher
is consistent with a diagnosis of ASD. The ASD sub-
jects’ scores for each question were significantly differ-
ent from the comparison subjects’. Additionally, the
mean RAADS-R scores of the ASD subjects and the
comparison subjects were significantly different in each
of the nine centers, as well as all of the centers com-
bined. Both the clinically assigned question-domains and
the statistically derived factors demonstrated high inter-
nal consistency. The RAADS-R had high test–retest
reliability in a limited number of subjects. The RAADS-R
was designed to assist clinicians in diagnosing adults (18?)
with suspected ASD. It is designed to be administered by
clinicians in a clinical setting. It is not intended to be a mail
in or an online screening instrument. The questions are
designed for individuals with average IQ and above. This is
a population with mild or subclinical ASD. These individ-
uals often escape diagnosis. The RAADS-R was specifically
designed to capture that population.
Limitations
Scales based on self-reports have inherent limitations:
First, a subject may not understand a question, and while
Table 7 Test-retest data statistical analysis
Subject group Number Pearson r= Spearman Rho=
All subjects 30 .987 .956
Autistic 7 1 1
Asperger 8 .939 .952
Comparisons 15 .874 .764
Table 8 RAADS-R scores and ranges by research center: ASD
subjects
Research center N RAADS-R scores
Mean 146 Min Max
UCLA 53 146 84 222
Yale 31 115 48 178
Mount Sinai 19 123 73 166
University of Utah 7 92 72 109
Monsah University, Australia 13 138 62 172
Aspect, Sydney 14 118 58 193
Griffith University, Australia 42 146 56 227
Geneva Center, Canada 8 148 107 216
University of London 14 135 67 205
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answering to the best of their ability, give a misleading
answer. This was mitigated in the present study by having a
clinician remain with the subject to clarify possible mis-
understandings during the administration of the RAADS-R.
Second is the issue of unawareness i.e., ‘‘denial’’ of
symptoms or over reporting of symptoms. To control for
this we added the SRS-A, which is a second party instru-
ment. The concordance rate was 95.95%, which indicates
good concurrent validity. However, since only 69 subjects
were available to complete the SRS-A, further studies are
warranted.
Six subjects whose clinical diagnoses and ADOS mod-
ule 4 scores placed them in the ASD group, scored below
the RAADS-R ASD cut off point of 65. Their mean age
was 19.9 years. Each of these six ‘‘false negative’’ subjects
was reported by their family members to be invested in
appearing ‘‘as normal as they could be.’’ The ANOVA
results show a positive correlation with age in the ASD
subjects with older subjects scoring higher (see Results
section). Possible explanations are: (a) the younger subjects
were denying symptoms, (b) the younger subjects received
treatment since childhood and now believed they were
‘‘normal,’’ and (c) three of the cases from Yale’s sample
have low functioning siblings with autism. These subjects
may see themselves relatively unaffected for this reason.
This stresses the importance for clinicians to search very
carefully for symptoms when diagnosing young adults,
given their propensity to want to ‘‘look as normal as
possible.’’
Another confounding factor is that the same symptoms
of ASD reported to be unobtrusive by some subjects may
be serious to incapacitating in others. For instance, a young
man reported that hypersensitivity to lights and sounds
caused him to be ‘‘completely socially isolated,’’ while
another with the same symptoms told us, ‘‘I go to carnivals,
circuses, and state fairs, every chance I get—I enjoy the
flashing lights and sounds of the barkers and noises the
merry go round makes.’’ ‘‘And I stay as long as I can,’’ he
added with a smile.
Factor Analysis
As noted in the Results section, four factors emerged from
Factor Analysis. The Cronbach alpha coefficients were sat-
isfactory (social relatedness = .93, circumscribed inter-
ests = .95, sensory motor = .87, social anxiety = .89),
indicating good internal consistency. For the clinical
domain, the Cronbach alpha for language was the weakest.
Factor IV contains questions relating to social anxiety and
anxiety in general. This factor is important to examine.
Targeting the social anxiety questions within the instrument
may help the clinician differentiate social anxiety from ASD.
The two diagnoses are often difficult to differentiate.
University Effect
As shown in the results section, there were significant
differences of the mean RAADS-R scores among the nine
research centers. This is most likely due to a large variation
in the number of subjects per center (maximum 53 to a
minimum of 7). Since the mean RAADS-R score for each
center was significantly different from the mean RAADS-R
scores of the comparison subjects (p \ .0001), it is likely
that the differences among centers would diminish if those
with fewer subjects were to expand their database. Further
validation studies are indicated.
Relevance to DSM-V
Results show significant statistical differences between the
autism and Asperger’s subjects and comparison subjects
with and without another DSM-IV-TR diagnosis. There
were no significant differences between the autism and
Asperger’s groups, which supports the newly proposed
DSM-V diagnostic criteria. Recently proposed DSM-V
criteria combines the two groups, creating an Autism
Spectrum Disorder diagnosis.
Conclusions
The RAADS-R proved to be highly accurate in discrimi-
nating between subjects with ASD and those without a
DSM-IV-TR diagnosis and with another DSM-IV-TR
diagnosis (sensitivity = 97%, specificity = 100%, test–
retest reliability = .987, accuracy = 98.5%,). No difficul-
ties were reported in administration even though subjects
were evaluated at nine medical centers on three continents.
Mean RAADS-R scores were highly significantly different
(p \ .0001) between ASD and comparison subjects at each
of the nine centers, and all eighty questions were signifi-
cantly different between ASD and comparison subjects.
The fact that this was true even when the comparison cases
had a variety of DSM-IV-TR diagnoses other than ASD
makes the RAADS-R particularly useful in adult clinical
settings.
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Appendix 1: The Ritvo Autism Asperger’s Diagnostic Scale-Revised (RAADS-R) and Scoring Instructions
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Appendix 2: Instructions for Scoring the Scale
The scale contains two types of questions:
1. 64 questions describing specific symptoms of ASD.
These are scored in order of severity from: ‘‘true now
and when I was young’’ = 3, to ‘‘never true’’ = 0.
2. 16 questions describing non symptomatic (normative)
behaviors. These are score: ‘‘true now and when I was
young’’ = 0 to ‘‘never true’’ = 3. These questions
have asterisks by their number (Table 9).
Table 9 Scores for the four possible answers
Answer checked by the subject True now and
when I was young
Only true now True only when i was young Never true
Symptom based questions 3 2 1 0
N = 64
Example: ‘‘I take things too literally
so I often miss what
people are trying to say’’.
(No asterisk after question number)
Normative questions 0 1 2 3
N = 16
Example: ‘‘I’’ * ‘‘I am a sympathetic person’’.
(Asterisk after question number)
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